Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Biosimilar market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biosimilar Market by XYZResearch Include
- China
- EU
- North America
- Japan
- India
- Southeast Asia
- South America
- Middle East and Africa
Competitive Analysis; Who are the Major Players in Biosimilar Market?
- Pfizer
- Roche
- Eli Lilly
- Bayer
- Amgen
- Sanofi-Aventis
- Johnson & Johnson
- Novo Nordisk
- Merck
Major Type of Biosimilar Covered in XYZResearch report:
- Antibody
- Hormone
- Growth Factors
- Other
Application Segments Covered in XYZResearch Market
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Post-pandemic Era - Global Biosimilar Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Table of Contents
Global Biosimilar Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Antibody -Product Introduction and Major Manufacturers
1.1.2 Hormone -Product Introduction and Major Manufacturers
1.1.3 Growth Factors -Product Introduction and Major Manufacturers
1.1.4 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Biosimilar Status and Prospect (2016-2027)
2.1.1 China Biosimilar Market Size and Growth Rate (2016-2027)
2.1.2 China Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Biosimilar Status and Prospect (2016-2027)
2.2.1 EU Biosimilar Market Size and Growth Rate (2016-2027)
2.2.2 EU Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Biosimilar Status and Prospect (2016-2027)
2.3.1 USA Biosimilar Market Size and Growth Rate (2016-2027)
2.3.2 USA Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Biosimilar Status and Prospect (2016-2027)
2.4.1 Japan Biosimilar Market Size and Growth Rate (2016-2027)
2.4.2 Japan Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Biosimilar Status and Prospect (2016-2027)
2.5.1 India Biosimilar Market Size and Growth Rate (2016-2027)
2.5.2 India Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Biosimilar Status and Prospect (2016-2027)
2.6.1 Southeast Asia Biosimilar Market Size and Growth Rate (2016-2027)
2.6.2 Southeast Asia Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Biosimilar Status and Prospect (2016-2027)
2.7.1 South America Biosimilar Market Size and Growth Rate (2016-2027)
2.7.2 South America Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Biosimilar Status and Prospect (2016-2027)
2.8.1 Biosimilar Market Size and Growth Rate (2016-2027)
2.8.2 Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Biosimilar Market Assessment by Segment
3.1 Global Biosimilar Capacity and Growth Rate
3.2 Global Biosimilar Sales by Type
3.3 Global Biosimilar Sales Revenue by Type
3.4 Global Biosimilar Consumption by Application
4 Global Biosimilar Market Assessment by Regions
4.1 Global Biosimilar Production Analysis and Forecast by Regions (2016-2027)
4.2 Global Biosimilar Sales Analysis and Forecast by Regions (2016-2027)
4.3 Global Biosimilar Sales Revenue Analysis and Forecast by Regions (2016-2027)
5 Value Chain (Impact of COVID-19)
5.1 Biosimilar Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Biosimilar Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Biosimilar Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Biosimilar Sales Market Share of Manufacturers (2019-2020)
6.3 Global Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)
7 Biosimilar Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer Biosimilar Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche Biosimilar Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Eli Lilly
7.3.1 Eli Lilly Company Profiles
7.3.2 Eli Lilly Product Introduction
7.3.3 Eli Lilly Biosimilar Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Bayer
7.4.1 Bayer Company Profiles
7.4.2 Bayer Product Introduction
7.4.3 Bayer Biosimilar Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Amgen
7.5.1 Amgen Company Profiles
7.5.2 Amgen Product Introduction
7.5.3 Amgen Biosimilar Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Sanofi-Aventis
7.6.1 Sanofi-Aventis Company Profiles
7.6.2 Sanofi-Aventis Product Introduction
7.6.3 Sanofi-Aventis Biosimilar Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Profiles
7.7.2 Johnson & Johnson Product Introduction
7.7.3 Johnson & Johnson Biosimilar Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Profiles
7.8.2 Novo Nordisk Product Introduction
7.8.3 Novo Nordisk Biosimilar Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Merck
7.9.1 Merck Company Profiles
7.9.2 Merck Product Introduction
7.9.3 Merck Biosimilar Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Biosimilar Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Biosimilar Sales (K Unit) by Type (2015-2026)
Figure Global Biosimilar Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Biosimilar Sales Market Share (%) by Type (2019 -2020)
Table Global Biosimilar Sales Value (Million USD) by Type (2015-2026)
Figure Global Biosimilar Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Biosimilar Sales Value Market Share (%) by Type (2019-2020)
Table Global Biosimilar Sales (K Unit) by Application (2015-2026)
Figure China Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table China Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table India Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Biosimilar Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Biosimilar Capacity (K Units) and Growth Rate (2015-2026)
Table Global Biosimilar Sales (Unit) by Type (2015-2026)
Figure Global Biosimilar Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Biosimilar Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Biosimilar Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Biosimilar Consumption (Unit) by Application (2015-2026)
Figure Global Biosimilar Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Biosimilar Production (K Unite) by Regions (2015-2020)
Table Global Biosimilar CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Biosimilar Production Share by Regions (2019-2020)
Table Global Biosimilar Sales (K Unite) by Regions (2015-2020)
Table Global Biosimilar CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Biosimilar Sales Share by Regions (2019-2020)
Table Global Biosimilar Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Biosimilar CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Biosimilar Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Biosimilar
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Biosimilar
Figure Cost Structure of Biosimilar in 2020
Table Global Biosimilar Capacity Share of Manufacturers (2019-2020)
Figure Global Biosimilar Capacity Share of Manufacturers (2019-2020)
Table Global Biosimilar Sales Market Share of Manufacturers (2019-2020)
Figure Global Biosimilar Sales Market Share of Manufacturers (2019-2020)
Table Global Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Biosimilar Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Pfizer Profiles
Table Pfizer Biosimilar Product Introduction
Table Pfizer Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pfizer SWOT Analysis
Table Roche Profiles
Table Roche Biosimilar Product Introduction
Table Roche Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Roche SWOT Analysis
Table Eli Lilly Profiles
Table Eli Lilly Biosimilar Product Introduction
Table Eli Lilly Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Eli Lilly SWOT Analysis
Table Bayer Profiles
Table Bayer Biosimilar Product Introduction
Table Bayer Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Bayer SWOT Analysis
Table Amgen Profiles
Table Amgen Biosimilar Product Introduction
Table Amgen Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Amgen SWOT Analysis
Table Sanofi-Aventis Profiles
Table Sanofi-Aventis Biosimilar Product Introduction
Table Sanofi-Aventis Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Sanofi-Aventis SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Biosimilar Product Introduction
Table Johnson & Johnson Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Novo Nordisk Profiles
Table Novo Nordisk Biosimilar Product Introduction
Table Novo Nordisk Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Novo Nordisk SWOT Analysis
Table Merck Profiles
Table Merck Biosimilar Product Introduction
Table Merck Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Merck SWOT Analysis
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
